Astrana Health, Inc.
ASTH
$29.34
$0.1450.50%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 39.93% | 49.52% | 40.15% | 34.42% | -22.69% |
Total Depreciation and Amortization | 46.09% | 25.26% | 6.25% | 1.17% | -5.49% |
Total Amortization of Deferred Charges | 82.05% | 60.17% | 36.53% | 12.99% | 7.49% |
Total Other Non-Cash Items | -46.62% | 28.81% | -10.18% | -15.26% | 103.52% |
Change in Net Operating Assets | -155.48% | -63,043.90% | -103.69% | -1,363.48% | 138.43% |
Cash from Operations | -38.41% | -22.67% | 1.02% | -16.93% | 992.38% |
Capital Expenditure | 43.84% | 33.06% | 30.81% | -24.36% | 10.05% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -661.30% | -701.95% | -272.31% | 60.18% | -410.50% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1,199.49% | -373.12% | -249.92% | -194.73% | -106.70% |
Cash from Investing | -316.92% | -1,298.45% | -8,510.47% | -821.17% | -317.87% |
Total Debt Issued | 9,420.12% | 10,965.03% | 8,644.94% | 7,807.92% | 86.34% |
Total Debt Repaid | -17,320.62% | -4,641.18% | -4,497.53% | -4,539.77% | 70.88% |
Issuance of Common Stock | -89.66% | -96.82% | -96.88% | -83.15% | 42.96% |
Repurchase of Common Stock | 46.38% | 56.35% | 96.56% | -5.64% | -0.42% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -1,552.15% | -342.44% | -342.44% | -342.44% | 71.44% |
Other Financing Activities | -1,685.35% | -181.57% | -43.24% | -8.59% | 93.13% |
Cash from Financing | 6,112.81% | 2,055.53% | 521.67% | 117.03% | 88.98% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -17.63% | -47.22% | 65.87% | -88.85% | 534.99% |